Risperidone inhibits voltage-gated sodium channels. 2014

Jan M Brauner, and Sabine Hessler, and Teja W Groemer, and Christian Alzheimer, and Tobias Huth
Department of Psychiatry and Psychotherapy, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Institute of Physiology and Pathophysiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsstr. 17, 91054 Erlangen, Germany.

In contrast to several other antipsychotic drugs, the effects of the atypical antipsychotic risperidone on voltage-gated sodium channels have not been characterized yet, despite its wide clinical use. Here we performed whole-cell voltage-clamp recordings to analyze the effects of risperidone on voltage-dependent sodium currents of N1E-115 mouse neuroblastoma cells carried by either endogenous sodium channels or transfected NaV1.6 channels. Risperidone inhibited both endogenous and NaV1.6-mediated sodium currents at concentrations that are expected around active synaptic release sites owing to its strong accumulation in synaptic vesicles. When determined for pharmacologically isolated NaV1.6, risperidone inhibited peak inward currents with an IC50 of 49 µM. Channel block occurred in a state-dependent fashion with risperidone displaying a fourfold higher affinity for the inactivated state than for the resting state. As a consequence of the low state dependence, risperidone produced only a small, but significant leftward shift of the steady-state inactivation curve and it required concentrations ≥ 30 µM to significantly slow the time course of recovery from inactivation. Risperidone (10 µM) gave rise to a pronounced use-dependent block when sodium currents were elicited by trains of brief voltage pulses at higher frequencies. Our data suggest that, compared to other antipsychotic drugs as well as to local anesthetics and sodium channel-targeting anticonvulsants, risperidone displays an unusual blocking profile where a rather low degree of state dependence is associated with a prominent use-dependent block.

UI MeSH Term Description Entries
D008564 Membrane Potentials The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization). Resting Potentials,Transmembrane Potentials,Delta Psi,Resting Membrane Potential,Transmembrane Electrical Potential Difference,Transmembrane Potential Difference,Difference, Transmembrane Potential,Differences, Transmembrane Potential,Membrane Potential,Membrane Potential, Resting,Membrane Potentials, Resting,Potential Difference, Transmembrane,Potential Differences, Transmembrane,Potential, Membrane,Potential, Resting,Potential, Transmembrane,Potentials, Membrane,Potentials, Resting,Potentials, Transmembrane,Resting Membrane Potentials,Resting Potential,Transmembrane Potential,Transmembrane Potential Differences
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014150 Antipsychotic Agents Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. Antipsychotic,Antipsychotic Agent,Antipsychotic Drug,Antipsychotic Medication,Major Tranquilizer,Neuroleptic,Neuroleptic Agent,Neuroleptic Drug,Neuroleptics,Tranquilizing Agents, Major,Antipsychotic Drugs,Antipsychotic Effect,Antipsychotic Effects,Antipsychotics,Major Tranquilizers,Neuroleptic Agents,Neuroleptic Drugs,Tranquillizing Agents, Major,Agent, Antipsychotic,Agent, Neuroleptic,Drug, Antipsychotic,Drug, Neuroleptic,Effect, Antipsychotic,Major Tranquilizing Agents,Major Tranquillizing Agents,Medication, Antipsychotic,Tranquilizer, Major
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D061567 Voltage-Gated Sodium Channel Blockers A class of drugs that inhibit the activation of VOLTAGE-GATED SODIUM CHANNELS. Channel Blockers, Voltage-Gated Sodium,Voltage-Gated Sodium Channel Antagonists,Voltage-Gated Sodium Channel Inhibitors,Channel Blockers, Voltage Gated Sodium,Voltage Gated Sodium Channel Antagonists,Voltage Gated Sodium Channel Blockers,Voltage Gated Sodium Channel Inhibitors
D062557 NAV1.6 Voltage-Gated Sodium Channel A voltage-gated sodium channel subtype found widely expressed in neurons of the central and peripheral nervous systems. Defects in the SCN8A gene which codes for the alpha subunit of this sodium channel are associated with ATAXIA and cognitive deficits. Voltage-Gated Sodium Channel Type 8 Subunit alpha,SCN8A Sodium Channel alpha Subunit,Type 8 Voltage-Gated Sodium Channel,Voltage-Gated Sodium Channel Type 8,NAV1.6 Voltage Gated Sodium Channel,Type 8 Voltage Gated Sodium Channel,Voltage Gated Sodium Channel Type 8,Voltage Gated Sodium Channel Type 8 Subunit alpha

Related Publications

Jan M Brauner, and Sabine Hessler, and Teja W Groemer, and Christian Alzheimer, and Tobias Huth
June 2015, Current opinion in pharmacology,
Jan M Brauner, and Sabine Hessler, and Teja W Groemer, and Christian Alzheimer, and Tobias Huth
February 2001, Current opinion in pharmacology,
Jan M Brauner, and Sabine Hessler, and Teja W Groemer, and Christian Alzheimer, and Tobias Huth
October 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Jan M Brauner, and Sabine Hessler, and Teja W Groemer, and Christian Alzheimer, and Tobias Huth
January 2004, Annual review of pharmacology and toxicology,
Jan M Brauner, and Sabine Hessler, and Teja W Groemer, and Christian Alzheimer, and Tobias Huth
January 2022, Frontiers in pharmacology,
Jan M Brauner, and Sabine Hessler, and Teja W Groemer, and Christian Alzheimer, and Tobias Huth
December 2004, Current drug targets. CNS and neurological disorders,
Jan M Brauner, and Sabine Hessler, and Teja W Groemer, and Christian Alzheimer, and Tobias Huth
January 2014, Handbook of experimental pharmacology,
Jan M Brauner, and Sabine Hessler, and Teja W Groemer, and Christian Alzheimer, and Tobias Huth
November 2000, Neuron,
Jan M Brauner, and Sabine Hessler, and Teja W Groemer, and Christian Alzheimer, and Tobias Huth
November 2002, Epilepsia,
Jan M Brauner, and Sabine Hessler, and Teja W Groemer, and Christian Alzheimer, and Tobias Huth
December 2008, Neuroreport,
Copied contents to your clipboard!